Aarti Industries trades higher on commissioning Phase I of Zone IV project at Gujarat
Aarti Industries is currently trading at Rs. 494.00, up by 2.95 points or 0.60% from its previous closing of Rs. 491.05 on the BSE.
The scrip opened at Rs. 490.15 and has touched a high and low of Rs. 494.20 and Rs. 485.80 respectively. So far 15348 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 551.45 on 25-Aug-2026 and a 52 week low of Rs. 338.20 on 21-Jan-2026.
Last one week high and low of the scrip stood at Rs. 520.80 and Rs. 485.80 respectively. The current market cap of the company is Rs. 17721.01 crore.
The promoters holding in the company stood at 41.82%, while Institutions and Non-Institutions held 28.10% and 30.07% respectively.
Aarti Industries has successfully commissioned Phase I of its Zone IV project at Jhagadia, Gujarat. Phase I brings together Calcium Chloride, PEDA (2-Phenyl Ethyl Diethyl Aniline) and a part of its Multipurpose Plant (MPP), creating complementary capabilities in downstream integration, diversified end-use applications, and flexible multi-product manufacturing. The platform is designed to support the commercialisation of high-value and niche products, with several products planned from Zone IV expected to be manufactured in India for the first time.
PEDA extends the company’s existing Ethylation platform further downstream, building on the Company’s established 2,6-Diethyl Aniline capabilities and strengthening its participation in value-added products catering primarily to agrochemical applications. The Calcium Chloride facility strengthens the company’s Energy & Additives portfolio, with applications across sectors including oilfield and energy-related markets. The Multipurpose Plant provides a flexible manufacturing platform to scale pilot-validated processes into commercial production across multiple products and advanced chemistries, enabling faster response to evolving customer and market requirements.
With Phase I commissioning now completed, the company’s focus will progressively shift towards commercial qualification, customer approvals and disciplined ramp-up of the newly commissioned assets. Together, these facilities broaden Zone IV’s ability to address a diversified portfolio of applications spanning agrochemicals, pharmaceuticals, coatings, polymers and energy & additives, while strengthening the company’s ability to develop and commercialise high-value and niche products.
-96767.jpg)
